|
|
 |
|
Viewing report
|
|
|
|
Express Scripts, Inc. - Strategy and SWOT Report
Datamonitor, Oct 2011, Pages: 43
Express Scripts, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Express Scripts, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Express Scripts, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Express Scripts, Inc. including a breakdown and examination of key business segments
- Intelligence on Express Scripts, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Express Scripts, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Express Scripts is one of the largest pharmacy benefit management (PBM) companies in North America. The company provides a range of PBM services, including retail drug card programs, home delivery services, specialty services and other clinical management programs for clients such as health maintenance organizations, health insurers, third-party administrators, employers, government sponsored benefit plans and union-sponsored benefit plans. The company primarily operates in the US. It is headquartered in St. Louis, Missouri and employed about 13,170 people as of December 31, 2010. Express Scripts has signed a definitive agreement to acquire its rival, Medco Health Solutions for $29.1 billion. The company recorded revenues- of $44,973.2 million during the financial year (FY) ended December 2010, an increase of 81.9% over FY2009. The operating profit of the company was $2,070.9 million during FY2010, an increase of 38.3% over FY2009. The net profit was $1,181.2 million in FY2010, an increase of 42.7% over FY2009. - Including retail pharmacy co-payments.
Reasons to Purchase:
- Gain understanding of Express Scripts, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Express Scripts, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Express Scripts, Inc.’s business structure, strategy and prospects
|
|
|
|
